Saber Ghazizadeh Darband

Saber Ghazizadeh Darband

Auto-generated profile, based on publicly available information

Saber Ghazizadeh Darband

Department of Surgery Orthopaedic Research Lab McGill University Montreal Quebec Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SDSaber G. Darband
Saber G. Darband
MKMojtaba Kaviani
Mojtaba Kaviani
BYBahman Yousefi
Bahman Yousefi
SSShirin Sadighparvar
Shirin Sadighparvar
FPFirouz G. Pakdel
Firouz G. Pakdel
MMMaryam Majidinia
Maryam Majidinia

1 August 2018 in Ageing Research Reviews
Verified
Journal Article
Closed access
MMMaryam Majidinia
Maryam Majidinia
RRRussel J. Reiter
Russel J. Reiter
SSSeyed Kazem Shakouri
Seyed Kazem Shakouri
IMIraj Mohebbi
Iraj Mohebbi
Mojgan RastegarMojgan Rastegar
Mojgan Rastegar
BYBahman Yousefi
Bahman Yousefi

1 September 2018 in DNA Repair
Verified
Journal Article
Closed access
MMMohammad Mirza-Aghazadeh-Attari
Mohammad Mirza-Aghazadeh-Attari
SDSaber Ghazizadeh Darband
Saber Ghazizadeh Darband
MKMojtaba Kaviani
Mojtaba Kaviani
AMAinaz Mihanfar
Ainaz Mihanfar
JAJavad Aghazadeh Attari
Javad Aghazadeh Attari
MMMaryam Majidinia
Maryam Majidinia

14 March 2025 in Science Advances
Verified
Journal Article
Open access
MMMatthew Mannarino
Matthew Mannarino
HCHosni CHERIF
Hosni CHERIF
SGSaber Ghazizadeh
Saber Ghazizadeh
OMOliver Wu Martinez
Oliver Wu Martinez
KSKai Sheng
Kai Sheng
Lisbet HaglundLisbet Haglund
Lisbet Haglund
Senescent cells (SnCs) accumulate because of aging and external cellular stress throughout the body. They adopt a senescence-associated secretory phenotype (SASP) and release inflammatory and degenerative factors that actively contribute to age-related diseases, such as low back pain (LBP). The senolytics, o -vanillin and RG-7112, remove SnCs in human intervertebral discs (IVDs) and reduce SASP release, but it is unknown whether they can treat LBP. sparc −/− mice, with LBP, were treated orally with o -vanillin and RG-7112 as single or combination treatments. Treatment reduced LBP and SASP factor release and removed SnCs from the IVD and spinal cord. Treatment also lowered degeneration scores in the IVDs, improved vertebral bone quality, and reduced the expression of pain markers in the spinal cord. Together, our data suggest RG-7112 and o -vanillin as potential disease-modifying drugs for LBP and other painful disorders linked to cell senescence.

1 June 2018 in DNA Repair
Verified
Journal Article
Closed access
MMMaryam Majidinia
Maryam Majidinia
SDSaber Ghazizadeh Darband
Saber Ghazizadeh Darband
Mojtaba KavianiMojtaba Kaviani
Mojtaba Kaviani
SNSeyed Mohammad Nabavi
Seyed Mohammad Nabavi
RJRana Jahanban-Esfahlan
Rana Jahanban-Esfahlan
BYBahman Yousefi
Bahman Yousefi

1 December 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
SSShirin Sadighparvar
Shirin Sadighparvar
SDSaber Ghazizadeh Darband
Saber Ghazizadeh Darband
FGFirouz Ghaderi-Pakdel
Firouz Ghaderi-Pakdel
AMAinaz Mihanfar
Ainaz Mihanfar
MMMaryam Majidinia
Maryam Majidinia